Infinity Pharmaceuticals Company Profile

04:20 EDT 25th June 2018 | BioPortfolio

The mission of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug technologies. We believe that our small molecule discovery and development capabilities, strategic partnerships, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients. IPI-504, our lead product candidate, is currently being studied in two disease-focused Phase I clinical trials. IPI-504 is a proprietary, targeted cancer therapy that inhibits heat shock protein 90, or Hsp90. We believe that the inhibition of Hsp90 has broad therapeutic potential for patients with solid and hematological tumors, including cancers that are resistant to other drugs, and that our small molecule technologies and expertise have resulted in a drug candidate with the potential to be a best-in-class Hsp90 inhibitor. Our next most advanced program is directed against the Hedgehog cell signaling pathway. The Hedgehog pathway is believed to play a central role in allowing the proliferation and survival of certain cancer-causing cells, and is implicated in many of the most deadly cancers. We believe the application of our chemistry expertise has resulted in drug candidates that have the potential to be best-in-class systemic inhibitors of the Hedgehog pathway, actively interfering with its deleterious effects. The goal of our third program is to identify small molecule compounds that inhibit the Bcl-2 family of proteins. Using our proprietary small molecule drug discovery technologies, we have identified selective inhibitors of Bcl-2 and its related protein family member, Bcl-xL. We also have other research programs that target cancer and related conditions.


780 Memorial Drive
United States of America


Phone: 617-453-1000
Fax: 617-453-1001

News Articles [506 Associated News Articles listed on BioPortfolio]

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Analyzing Iqvia

Iqvia and Infinity Pharmaceuticals are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, d...

MaxCyte appoints Infinity Pharma's Claudio Dansky Ullmann as its chief medical officer

Ullmann was most recently the senior vice president and head of clinical development at Infinity Pharmaceuticals Inc, where he oversaw all clinical development and operations

The HCI Group Acquires MEDITECH Certified Partner Infinity HIT

The HCI Group, a healthcare IT consulting firm has acquired Infinity HIT, a MEDITECH Ready-Certified consulting firm to expand its health IT service offerings. The HCI Group plans to leverage the acqu...

Avengers: Infinity War - Wizards vs. The Prophet

At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA

Verastem has filed for FDA approval of duvelisib, a blood cancer drug the Needham, MA, company took a shot on in a 2016 bargain deal with Infinity Pharmaceuticals. Verastem will seek approval of duvel...

Glosfer veranstaltete Infinity Project Unpacked-Event zur Präsentation von Blockchain-Anwendungen

Mitarbeiter aus verschiedenen Abteilungen stellten Glosfers Technologie und den Geschäftsverkehr des Unternehmens sowie Fortschritt, Planung und Zeitplan des Infinity Projects vor. Teilnehmer hatt...

The New 'Infinity War' Trailer Is Here, Now Set Your Faces To Stunned

Marvel hinted at, and then promised us, a new "Avengers: Infinity War" trailer

Drugs and Medications [278 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Carboplatin [APP Pharmaceuticals, LLC]


Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

PubMed Articles [151 Associated PubMed Articles listed on BioPortfolio]

Calibrating a paracatadioptric camera by the property of the polar of a point at infinity with respect to a circle.

Two methods are presented for calibrating a paracatadioptric camera. A sphere in 3D space is projected to two parallel circles on which two tangents of a point and its antipode are parallel on the uni...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

Clinical Evaluation of the Infinity DBS System

The purpose of this post market study is to support the chronic clinical performance of the Infinity Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG), DBS leads, extensions a...

INFINITY™Total Ankle Replacement Follow-up

Study Title INFINITY™Total Ankle Replacement Follow-up (ITAR) Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or ...

UK Infinity, Post-Market Clinical Follow-up Study

Study Title UK Post-Market Clinical Follow-Up Of The INFINITY® Total Ankle System Study Design Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary...

Prospective Evaluation Comparing the Effects of Constant Current Versus Constant Voltage in Deep Brain Stimulation Using Hybrid Systems

This post-marketing evaluation has been designed to consistently investigate the subject's preference when switching from a Medtronic® constant voltage or constant current device to a St ...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Companies [1336 Associated Companies listed on BioPortfolio]

Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Inf...

Infinity Info Systems

Founded in 1987, Infinity Info Systems develops customer relationship management (CRM) and business analytics solutions for clients in the financial, life sciences, business services, media and manufa...

Infinity Group

Infinity Group is an RMB fund pioneer and the leader in cross border China RMB and dollar private equity funds. It is also the founder of the Infinity IP Bank, the hub for IP deve...

Infinity Technology, Inc

We realize both IT and corporate management play vital roles in the success of an organization, but speak different languages. Infinity Technology, Inc. has crafted everything necessary to unite these...

Infinity Healthcare Services LLC

Infinity Healthcare Services, LLC is a healthcare company formed to own and operate medical Imaging equipment throughout the United States. The company works directly with hospita...

More Information about "Infinity Pharmaceuticals" on BioPortfolio

We have published hundreds of Infinity Pharmaceuticals news stories on BioPortfolio along with dozens of Infinity Pharmaceuticals Clinical Trials and PubMed Articles about Infinity Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Infinity Pharmaceuticals Companies in our database. You can also find out about relevant Infinity Pharmaceuticals Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record